1. Home
  2. QUBT vs AGIO Comparison

QUBT vs AGIO Comparison

Compare QUBT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$7.85

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$32.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
AGIO
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
QUBT
AGIO
Price
$7.85
$32.81
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$17.50
$38.88
AVG Volume (30 Days)
6.3M
721.8K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
N/A
EPS
N/A
N/A
Revenue
$682,000.00
$43,011,000.00
Revenue This Year
$3,210.56
$76.75
Revenue Next Year
$51.26
$170.73
P/E Ratio
N/A
N/A
Revenue Growth
82.84
N/A
52 Week Low
$6.18
$22.24
52 Week High
$25.84
$46.00

Technical Indicators

Market Signals
Indicator
QUBT
AGIO
Relative Strength Index (RSI) 45.16 46.20
Support Level $7.57 $32.54
Resistance Level $9.25 $36.04
Average True Range (ATR) 0.34 1.33
MACD -0.02 0.04
Stochastic Oscillator 29.57 31.48

Price Performance

Historical Comparison
QUBT
AGIO

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: